Exane Derivatives’s Huntsman Corp HUN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1
Closed -$27 708
2018
Q3
$27 Sell
1
-252
-100% -$7.68K ﹤0.01% 666
2018
Q2
$7.49K Sell
253
-70
-22% -$2.17K ﹤0.01% 462
2018
Q1
$9.25K Buy
323
+86
+36% +$2.81K ﹤0.01% 421
2017
Q4
$7.88K Sell
237
-303
-56% -$9.28K ﹤0.01% 413
2017
Q3
$14.8K Buy
540
+342
+173% +$9.11K ﹤0.01% 370
2017
Q2
$5.12K Sell
198
-144
-42% -$3.57K ﹤0.01% 431
2017
Q1
$8.39K Sell
342
-633
-65% -$13.6K ﹤0.01% 357
2016
Q4
$18.6K Hold
975
﹤0.01% 370
2016
Q3
$15.9K Hold
975
﹤0.01% 378
2016
Q2
$13.1K Sell
975
-26,591
-96% -$390K ﹤0.01% 358
2016
Q1
$367K Sell
27,566
-8,450
-23% -$87.3K 0.05% 155
2015
Q4
$409K Buy
36,016
+2,684
+8% +$31.8K 0.06% 129
2015
Q3
$323K Buy
33,332
+5,531
+20% +$95.2K 0.04% 153
2015
Q2
$614K Sell
27,801
-596
-2% -$13.5K 0.07% 129
2015
Q1
$630K Buy
28,397
+9,733
+52% +$217K 0.07% 123
2014
Q4
$425K Buy
+18,664
New +$453K 0.06% 154

Other funds holding HUN

Exane Derivatives's HUN Position: Q4 2018 in Review

Exane Derivatives sold out of Huntsman Corp (HUN) in Q4 2018, closing a stake of 1 share — an estimated $27 sold.

Exane Derivatives first reported a position in HUN in Q4 2014 and held it in 16 quarters. The position peaked at $630K in Q1 2015. 374 funds tracked by Wall St. Rank hold HUN as of Q4 2018.

  • Exane Derivatives reported no remaining Huntsman Corp position as of Q4 2018 after selling out during the quarter.
  • Exane Derivatives sold 1 Huntsman Corp share in Q4 2018, an estimated $27.
  • Exane Derivatives first reported a position in Huntsman Corp in Q4 2014 and held it in 16 quarters.
  • Exane Derivatives's Huntsman Corp position peaked at $630K in Q1 2015.
  • 374 funds tracked by Wall St. Rank held Huntsman Corp as of Q4 2018.

Based on Exane Derivatives's 13F filing for Q4 2018, filed 31 Jan 2019.